12 January 2017 - Drugstore chain CVS Health has cut the price of a generic version of Impax Laboratories' emergency allergy injection, a device similar to Mylan's controversial EpiPen.

Mylan, which has been lambasted by consumers and lawmakers for raising EpiPen prices six-fold in less than a decade, said last month it would start selling a generic version of EpiPen for $300 per two-pack, a more than 50 percent discount.

CVS's move comes after health insurer Cigna revised its coverage list to include the generic version of EpiPen instead of the branded version.

"These formulary changes were anticipated and are why we anticipate successful generic utilisation," Mylan spokeswoman Julie Knell said in an email.

Read Reuters article